CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 103 enrolled
Drug / intervention
Inhaled Steroids +2 moredrug
Likely dose
Azithromycin Pill 500mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06272370
NCT06272370Phase 4Completed

Individualizing Treatment for Asthma in Primary Care

DARTNet Institute·interventional·Posted Feb 22, 2024·Updated Apr 20, 2025

In Brief

A Phase 4 clinical trial evaluating Asthma Symptom Monitoring online tools, Inhaled Steroids, and 1 other intervention for Asthma and 6 related conditions. Completed, enrolled 103 participants across 1 site.

Detailed Summary

This is a patient level randomized trial for teenagers and adults with asthma who will be randomized to four arms - enhance usual care, rescue inhaled corticosteroids, azithromycin and both rescue inhaled corticosteroids and azithromycin. Participants in all arms will be offered access to an online asthma symptom monitoring system.

Study Details

Timeline

Phase 4CompletedFinished
202420252026
First PostedFeb 22, 2024
Enrollment StartFeb 1, 2024
Primary CompletionSep 30, 2024
Study CompletionDec 31, 2024
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 2.4 years ago

Interventions

Asthma Symptom Monitoring online toolsother

All participants will be provided access to the Asthma Symptom Monitoring tools and 3/4's will be randomized to one of the other three arms above

Inhaled Steroidsdrug

participants will use either a combination of budesonide/formoterol or mometasone/formoterol as both controller and rescue therapy or a stand alone inhaled steroid (beclomethasone, budesonide, fluticasone, mometasone, ciclesodine) of their choice with their current reliever therapy or be converted to budesonide/albuterol as rescue therapy

Azithromycin Pilldrug

Participants will take 500mg of azithromycin three times a week or 10mg/kg if under 50Kg which may be reduced to 250mg/Kg for side effects